Hyperhomocysteinemia Promotes Inflammatory Monocyte Generation and Accelerates Atherosclerosis in Transgenic Cystathionine β-Synthase–Deficient Mice
Authors:
- Xiaohua JiangXJXiaohua Jiang
- Pu FangPFPu Fang
- Yan YanYYYan Yan
- Jian SongJSJian Song
- Sapna GuptaSGSapna Gupta
- Andrew I. SchaferASAndrew I. Schafer
- William DuranteWDWilliam Durante
- Warren D. KrugerWKWarren D. Kruger
- Xiaofeng YangXYXiaofeng Yang
- Hong WangHong Wang
- 10 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (19) , 1893-1902
Abstract
Background— Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular disease. Monocytes display inflammatory and resident subsets and commit to specific functions in atherogenesis. In this study, we examined the hypothesis that HHcy modulates monocyte heterogeneity and leads to atherosclerosis. Methods and Results— We established a novel atherosclerosis-susceptible mouse model with both severe HHcy and hypercholesterolemia in which the mouse cystathionine β-synthase (CBS) and apolipoprotein E (apoE) genes are deficient and an inducible human CBS transgene is introduced to circumvent the neonatal lethality of the CBS deficiency ( Tg-hCBS apoE −/− Cbs −/− mice). Severe HHcy accelerated atherosclerosis and inflammatory monocyte/macrophage accumulation in lesions and increased plasma tumor necrosis factor-α and monocyte chemoattractant protein-1 levels in Tg-hCBS apoE −/− Cbs −/− mice fed a high-fat diet. Furthermore, we characterized monocyte heterogeneity in Tg-hCBS apoE −/− Cbs −/− mice and another severe HHcy mouse model ( Tg-S466L Cbs −/− ) with a disease-relevant mutation ( Tg-S466L ) that lacks hyperlipidemia. HHcy increased monocyte population and selective expansion of inflammatory Ly-6C hi and Ly-6C mid monocyte subsets in blood, spleen, and bone marrow of Tg-S466L Cbs −/− and Tg-hCBS apoE −/− Cbs −/− mice. These changes were exacerbated in Tg-S466L Cbs −/− mice with aging. Addition of l -homocysteine (100 to 500 μmol/L), but not l -cysteine, maintained the Ly-6C hi subset and induced the Ly-6C mid subset in cultured mouse primary splenocytes. Homocysteine-induced differentiation of the Ly-6C mid subset was prevented by catalase plus superoxide dismutase and the NAD(P)H oxidase inhibitor apocynin. Conclusion— HHcy promotes differentiation of inflammatory monocyte subsets and their accumulation in atherosclerotic lesions via NAD(P)H oxidase–mediated oxidant stress.Keywords
This publication has 31 references indexed in Scilit:
- Mouse models of cystathionine β‐synthase deficiency reveal significant threshold effects of hyperhomocysteinemiaThe FASEB Journal, 2008
- Regulatory role of thioredoxin in homocysteine‐induced monocyte chemoattractant protein‐1 secretion in monocytes/macrophagesFEBS Letters, 2008
- Cystathionine β-synthase p.S466L mutation causes hyperhomocysteinemia in miceHuman Mutation, 2008
- Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin AgeneBlood, 2007
- Differential Regulation of Homocysteine Transport in Vascular Endothelial and Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataJournal of Clinical Investigation, 2007
- Hyperhomocysteinemia Decreases Circulating High-Density Lipoprotein by Inhibiting Apolipoprotein A-I Protein Synthesis and Enhancing HDL Cholesterol ClearanceCirculation Research, 2006
- Homocysteine stimulates phosphorylation of NADPH oxidase p47phoxand p67phoxsubunits in monocytes via protein kinase Cβ activationBiochemical Journal, 2006
- Hyperhomocysteinemia inhibits post-injury reendothelialization in miceCardiovascular Research, 2006
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005